Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Found 510 record(s)

Req # A-2021-00026

This request follows on from: STANDING COMMITTEE ON ACCESS TO INFORMATION, PRIVACY AND ETHICS Parliament of Canada, Feb 19 2021. MindGeek: Feras Antoon. CEO MindGeek Canada. David Tassillo, chief operations officer, and Corey Urman, vice-president of product management. Members of parliament: Chris Warkentin, Brenda Shanahan, and Marie-Hélène Gaudreau I would like ALL the documents submitted by MindGeek between 5 Feb 2021 and 1 Sept 2021. I would like ALL email correspondence from MindGeek to the department + the above name MPs between 2019 and 1 Sept 2021. HELPFUL CONTEXT. MP. Shannon Stubbs asked during the hearing: “Yes. I want to ensure that we're prescriptive and thorough in the requests that we make. I think what we definitely have to have in the documents supplied will be a comprehensive breakdown of all the revenue streams, the equity in the company and explicitly who owns it, what the value is, and if there is any debt leveraging, who owns that debt. I think it would be beneficial to know how much revenue has been generated in the last five years and if there's enough money to make the case that they could be holding themselves to a higher standard, or ought to be. We'll also want to see any off-balance sheet entities for which fees and costs associated with revenue are deducted as costs for tax purposes, and, I think, probably tax payments, at least in Canada but ideally in all locations where there are subsidiaries of MindGeek.”

Organization: Office of the Information Commissioner of Canada

0 page(s)
September 2020

Req # A-2021-00028

I am requesting any document that outlines the policies & procedures for handling a privacy breach made by an employee of OIC.

Organization: Office of the Information Commissioner of Canada

109 page(s)
September 2020

Req # A-2020-00004

List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.

Organization: Patented Medicine Prices Review Board Canada

4 page(s)
September 2020

Req # A-2020-04135

Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

79 page(s)
September 2020

Req # A-2020-09098

Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
September 2020